Before forming his own consulting company in 1997, was VP for Medications Development and Project Management for G.D. Searle, Director of New Project Management for American Cyanamid and Acting Deputy Director of NIDA (NIH).
Dr. Buchman spent the next two years as a Research Associate in Medicinal Chemistry at the University of Kansas, Lawrence, KS. During his industrial career, Dr. Buchman has held various technical and managerial positions at Diamond Shamrock Corporation, SDS Biotech, Ricerca, QO Chemicals, G.D. Searle, Pharmacia Corporation, Universal Pharma Technologies, and Abbott Laboratories.
Dr. Grudzinskas' drug development career includes Vice President, Medications Development and Project Management, G.D. Searle and Company and Director, New Product Management at Lederle Laboratories.Prior to joining Searle, Dr. Grudzinskas was the first Director of the Medications Development Division of the National Institute on Drug Abuse (NIDA) at the NIH.
Mr. Ruminski is adjunct professor in the department of Biochemistry and Molecular Biology at Saint Louis University as well as an accomplished pharmaceutical scientist with over 34 years of research experience and project leadership at Monsanto, Searle, Pharmacia, and Pfizer.
Dr. Griggs is a scientific expert in the field of integrin biology with over 20 years of experience managing drug research programs at large pharmaceutical companies (Searle, Pharmacia, and Pfizer) and in a university-based translational pharmacology center (the Center for World Health & Medicine at Saint Louis University).
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.